These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19499987)

  • 21. Hereditary medullary thyroid cancer: age-appropriate thyroidectomy improves disease-free survival.
    Shepet K; Alhefdhi A; Lai N; Mazeh H; Sippel R; Chen H
    Ann Surg Oncol; 2013 May; 20(5):1451-5. PubMed ID: 23188542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
    Krampitz GW; Norton JA
    Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic thyroidectomy in MEN 2A syndrome.
    Mattavelli F; Seregni E; Collini P; Pasini B; Aiello A; Barbaccia C; Bimbi G; Riccio S; Santamaria S
    Tumori; 2003; 89(5):553-5. PubMed ID: 14870785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medullary thyroid carcinoma.
    Pacini F; Castagna MG; Cipri C; Schlumberger M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic thyroidectomy in the treatment of thyroid medullary carcinoma. Age for surgery?
    Hassett S; Costigan C; McDermott M; Fitzgerald RJ
    Eur J Pediatr Surg; 2000 Oct; 10(5):334-6. PubMed ID: 11194546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of patients with hereditary medullary thyroid carcinoma.
    Fitze G
    Eur J Pediatr Surg; 2004 Dec; 14(6):375-83. PubMed ID: 15630638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
    Allen SM; Bodenner D; Suen JY; Richter GT
    Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The surgical management of medullary thyroid cancer.
    Dackiw AP
    Otolaryngol Clin North Am; 2010 Apr; 43(2):365-74, ix. PubMed ID: 20510719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prophylactic thyroidectomy in medullary thyroid cancer].
    Peix JL; Lifante JC; Borson CF; Giraud S
    Bull Acad Natl Med; 2012 Oct; 196(7):1247-58; discussion 1258-60. PubMed ID: 23815012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Is immediate prophylactic thyroidectomy indispensable in familiar medullary thyroid carcinoma?].
    Cañizo A; Fanjul M; Cerdá J; Menárguez J; Parente A; Laín A; Carrera N; Rodríguez-Arnao MD; Rodríguez-Sánchez A; Polo JR; Vázquez J
    Cir Pediatr; 2008 Apr; 21(2):100-3. PubMed ID: 18624279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Video-assisted central compartment lymphadenectomy in a patient with a positive RET oncogene: initial experience.
    Miccoli P; Elisei R; Donatini G; Materazzi G; Berti P
    Surg Endosc; 2007 Jan; 21(1):120-3. PubMed ID: 16960675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
    Machens A; Lorenz K; Dralle H
    Ann Surg; 2009 Aug; 250(2):305-10. PubMed ID: 19638924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current approaches to medullary thyroid carcinoma, sporadic and familial.
    Fialkowski EA; Moley JF
    J Surg Oncol; 2006 Dec; 94(8):737-47. PubMed ID: 17131404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medullary thyroid carcinoma: surgical treatment advances.
    Dionigi G; Tanda ML; Piantanida E
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):158-62. PubMed ID: 18327036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G; Saeger HD; Roesner D; Schackert HK
    Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The RET gene and medullary thyroid cancer: from mutations to the planning of therapy].
    Conzo G; Ruggiero R; Palazzo A; Della Pietra C; Stanzione F; Livrea A; Docimo G
    Chir Ital; 2009; 61(5-6):531-8. PubMed ID: 20380254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
    Niccoli-Sire P; Murat A; Rohmer V; Gibelin H; Chabrier G; Conte-Devolx B; Visset J; Ronceray J; Jaeck D; Henry JF; Proye C; Carnaille B; Kraimps JL;
    Surgery; 2003 Dec; 134(6):1029-36; discussion 1036-7. PubMed ID: 14668737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members.
    Shaha AR; Cohen T; Ghossein R; Tuttle RM
    Laryngoscope; 2006 Sep; 116(9):1704-7. PubMed ID: 16955009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of preoperative basal calcitonin levels in the timing of prophylactic thyroidectomy in patients with germline RET mutations.
    Lifante JC; Blanchard C; Mirallié E; David A; Peix JL
    World J Surg; 2014 Mar; 38(3):576-81. PubMed ID: 24357249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.